{"protocolSection":{"identificationModule":{"nctId":"NCT00256152","orgStudyIdInfo":{"id":"CRD291"},"organization":{"fullName":"Abbott Medical Devices","class":"INDUSTRY"},"briefTitle":"Asymptomatic Atrial Fibrillation and Stroke Evaluation in Pacemaker Patients and the Atrial Fibrillation Reduction Atrial Pacing Trial","officialTitle":"Asymptomatic Atrial Fibrillation and Stroke Evaluation in Pacemaker Patients and the Atrial Fibrillation Reduction Atrial Pacing Trial"},"statusModule":{"statusVerifiedDate":"2019-02","overallStatus":"COMPLETED","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2004-09"},"primaryCompletionDateStruct":{"date":"2010-06","type":"ACTUAL"},"completionDateStruct":{"date":"2010-06","type":"ACTUAL"},"studyFirstSubmitDate":"2005-09-10","studyFirstSubmitQcDate":"2005-11-17","studyFirstPostDateStruct":{"date":"2005-11-21","type":"ESTIMATED"},"lastUpdateSubmitDate":"2019-02-01","lastUpdatePostDateStruct":{"date":"2019-02-04","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"Abbott Medical Devices","class":"INDUSTRY"},"collaborators":[{"name":"Population Health Research Institute","class":"OTHER"}]},"descriptionModule":{"briefSummary":"In patients with a standard indication for pacing and no previous history of AF, detection of Atrial High Rate Episodes predicts an increased risk of stroke and systemic embolism.\n\nOverdrive atrial pacing with the AF Suppression algorithm will reduce the risk of symptomatic AF in patients with standard indication for pacing and no previous history of AF."},"conditionsModule":{"conditions":["Hypertension","Atrial Fibrillation"],"keywords":["Atrial fibrillation","Pacemaker","AF suppression pacing","Indications for Pacemaker Implantation due to sinus node or atrio-ventricular node disease"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["PHASE4"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"PARALLEL","primaryPurpose":"TREATMENT","maskingInfo":{"masking":"NONE"}},"enrollmentInfo":{"count":2580,"type":"ACTUAL"}},"armsInterventionsModule":{"armGroups":[{"label":"AF Suppression OFF","type":"NO_INTERVENTION"},{"label":"AF Suppression ON","type":"EXPERIMENTAL","interventionNames":["Device: AF Suppression Pacing Algorithm"]}],"interventions":[{"type":"DEVICE","name":"AF Suppression Pacing Algorithm","armGroupLabels":["AF Suppression ON"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Composite of ischemic stroke & Non-CNS systemic embolism","timeFrame":"3 years"},{"measure":"Symptomatic or Asymptomatic AT documented by ECG","timeFrame":"3 years"}],"secondaryOutcomes":[{"measure":"Myocardial infarction [MI], Vascular death Composite of stroke, MI or vascular death","timeFrame":"3 years"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria\n\n1. Age ≥ 65 years\n2. History of hypertension requiring pharmacological therapy (≥ 4 weeks of therapy).\n3. Recent (\\< 8 weeks) St. Jude Medical Inc. pacemaker implant (IDENTITY® Adx DR (Model 5386/5380)), ICD implant (EPIC 2 or Atlas 2) or other St. Jude Medical Inc. pacemaker or ICD with the same capabilities.\n4. In pacemaker patients only the primary indication for pacing is sinus or AV node disease.\n\nExclusion Criteria\n\n1. Previous documented AF, atrial flutter (lasting greater than 5 minutes), or other sustained SVT (not including episodes detected by the device)\n2. Geographic/social or psychiatric factor likely to interfere with follow-up\n3. Requirement for oral anticoagulation (heart valve, deep vein thrombosis, etc.)","healthyVolunteers":false,"sex":"ALL","minimumAge":"65 Years","stdAges":["OLDER_ADULT"]},"contactsLocationsModule":{"overallOfficials":[{"name":"Stuart Connolly, MD","affiliation":"McMaster University","role":"STUDY_CHAIR"},{"name":"Stephan Hohnloser, MD","affiliation":"Goethe University","role":"STUDY_CHAIR"},{"name":"Carlos Morillo, MD","affiliation":"McMaster University","role":"PRINCIPAL_INVESTIGATOR"},{"name":"Jeff Healey, MD","affiliation":"McMaster University","role":"PRINCIPAL_INVESTIGATOR"},{"name":"Carsten Israel, MD","affiliation":"Goethe University","role":"PRINCIPAL_INVESTIGATOR"},{"name":"Michael Gold, MD","affiliation":"Medical University of South Carolina","role":"PRINCIPAL_INVESTIGATOR"},{"name":"Chu-Pak Lau, MD","affiliation":"The University of Hong Kong","role":"PRINCIPAL_INVESTIGATOR"},{"name":"Alessandro Capucci, MD","affiliation":"Ospedale Clinic, Piacenza Italy","role":"PRINCIPAL_INVESTIGATOR"}],"locations":[{"facility":"McMaster University","city":"Hamilton","state":"Ontario","country":"Canada","geoPoint":{"lat":43.25011,"lon":-79.84963}}]},"referencesModule":{"references":[{"pmid":"32701364","type":"DERIVED","citation":"Benz AP, Wang J, McIntyre WF, Wong JA, Crystal E, Shurrab M, Israel CW, Hohnloser SH, Gold MR, Connolly SJ, Healey JS. Active-Fixation Atrial Leads and the Risk of Atrial Fibrillation: Insights From ASSERT. Circ Arrhythm Electrophysiol. 2020 Sep;13(9):e008655. doi: 10.1161/CIRCEP.120.008655. Epub 2020 Jul 23. No abstract available."},{"pmid":"29764671","type":"DERIVED","citation":"Perera KS, Sharma M, Connolly SJ, Wang J, Gold MR, Hohnloser SH, Lau CP, Van Gelder IC, Morillo C, Capucci A, Israel CW, Botto G, Healey JS. Stroke type and severity in patients with subclinical atrial fibrillation: An analysis from the Asymptomatic Atrial Fibrillation and Stroke Evaluation in Pacemaker Patients and the Atrial Fibrillation Reduction Atrial Pacing Trial (ASSERT). Am Heart J. 2018 Jul;201:160-163. doi: 10.1016/j.ahj.2018.03.027. Epub 2018 Apr 18."},{"pmid":"24633881","type":"DERIVED","citation":"Brambatti M, Connolly SJ, Gold MR, Morillo CA, Capucci A, Muto C, Lau CP, Van Gelder IC, Hohnloser SH, Carlson M, Fain E, Nakamya J, Mairesse GH, Halytska M, Deng WQ, Israel CW, Healey JS; ASSERT Investigators. Temporal relationship between subclinical atrial fibrillation and embolic events. Circulation. 2014 May 27;129(21):2094-9. doi: 10.1161/CIRCULATIONAHA.113.007825. Epub 2014 Mar 14."},{"pmid":"23356818","type":"DERIVED","citation":"Lau CP, Gbadebo TD, Connolly SJ, Van Gelder IC, Capucci A, Gold MR, Israel CW, Morillo CA, Siu CW, Abe H, Carlson M, Tse HF, Hohnloser SH, Healey JS; ASSERT investigators. Ethnic differences in atrial fibrillation identified using implanted cardiac devices. J Cardiovasc Electrophysiol. 2013 Apr;24(4):381-7. doi: 10.1111/jce.12066. Epub 2013 Jan 28."},{"pmid":"22698765","type":"DERIVED","citation":"Hohnloser SH, Healey JS, Gold MR, Israel CW, Yang S, van Gelder I, Capucci A, Lau CP, Fain E, Morillo CA, Ha A, Carlson M, Connolly SJ; ASSERT Investigators. Atrial overdrive pacing to prevent atrial fibrillation: insights from ASSERT. Heart Rhythm. 2012 Oct;9(10):1667-73. doi: 10.1016/j.hrthm.2012.06.012. Epub 2012 Jun 12."},{"pmid":"22236222","type":"DERIVED","citation":"Healey JS, Connolly SJ, Gold MR, Israel CW, Van Gelder IC, Capucci A, Lau CP, Fain E, Yang S, Bailleul C, Morillo CA, Carlson M, Themeles E, Kaufman ES, Hohnloser SH; ASSERT Investigators. Subclinical atrial fibrillation and the risk of stroke. N Engl J Med. 2012 Jan 12;366(2):120-9. doi: 10.1056/NEJMoa1105575. Erratum In: N Engl J Med. 2016 Mar 10;374(10):998."}]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000001281","term":"Atrial Fibrillation"}],"ancestors":[{"id":"D000002318","term":"Cardiovascular Diseases"},{"id":"D000001145","term":"Arrhythmias, Cardiac"},{"id":"D000006331","term":"Heart Diseases"},{"id":"D000010335","term":"Pathologic Processes"}],"browseLeaves":[{"id":"M21996","name":"Stroke","relevance":"LOW"},{"id":"M9714","name":"Hypertension","relevance":"LOW"},{"id":"M4276","name":"Atrial Fibrillation","asFound":"Atrial Fibrillation","relevance":"HIGH"},{"id":"M4143","name":"Arrhythmias, Cardiac","relevance":"LOW"},{"id":"M9109","name":"Heart Diseases","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC23","name":"Symptoms and General Pathology"}]}},"hasResults":false}